scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1537-2995.2004.03300.X |
P698 | PubMed publication ID | 15157263 |
P50 | author | Shunji Mishiro | Q45614514 |
P2093 | author name string | Naokazu Takeda | |
Hisami Ikeda | |||
Kanji Fukai | |||
Shinichiro Sato | |||
Toshiaki Kato | |||
Kazuaki Takahashi | |||
Keiji Matsubayashi | |||
Hidekatsu Sakata | |||
Yasuhiro Nagaoka | |||
Mitsunobu Imai | |||
P2860 | cites work | Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository | Q43581611 |
Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L. | Q43635344 | ||
A case report: two patients with fulminant hepatitis E in Hokkaido, Japan. | Q43713352 | ||
Hepatitis E virus transmission to a volunteer | Q44391700 | ||
Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus | Q44502533 | ||
Identification of a novel variant of hepatitis E virus in Austria: sequence, phylogenetic and serological analysis | Q45739648 | ||
Identification of 2 novel isolates of hepatitis E virus in Argentina | Q45741677 | ||
Hepatitis E virus: can it be transmitted parenterally? | Q45745557 | ||
Vertical transmission of hepatitis E virus | Q45786178 | ||
Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000. | Q55239686 | ||
Sporadic Hepatitis E in Austria | Q56786160 | ||
Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan | Q34196037 | ||
A novel virus in swine is closely related to the human hepatitis E virus | Q34437217 | ||
Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal | Q34989483 | ||
Zoonotic transmission of hepatitis E virus from deer to human beings | Q40569571 | ||
Swine hepatitis E virus strains in Japan form four phylogenetic clusters comparable with those of Japanese isolates of human hepatitis E virus | Q42595601 | ||
Characterization of Japanese swine and human hepatitis E virus isolates of genotype IV with 99 % identity over the entire genome | Q42597074 | ||
Full-genome nucleotide sequence of a hepatitis E virus strain that may be indigenous to Japan | Q42656890 | ||
Genetic heterogeneity of hepatitis E virus | Q42658572 | ||
Analysis of the complete genome of indigenous swine hepatitis E virus isolated in Japan | Q42665298 | ||
The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States | Q42674645 | ||
Genetic heterogeneity of hepatitis E virus recovered from Japanese patients with acute sporadic hepatitis. | Q42676018 | ||
Prevalence, isolation, and partial sequence analysis of hepatitis E virus from domestic animals in China | Q42680283 | ||
Identification of two distinct genotypes of hepatitis E virus in a Japanese patient with acute hepatitis who had not travelled abroad | Q42680607 | ||
Identification of a novel strain of hepatitis E virus responsible for sporadic acute hepatitis in Taiwan | Q42680751 | ||
Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. | Q42692392 | ||
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population | Q43040535 | ||
P433 | issue | 6 | |
P921 | main subject | Japan | Q17 |
hepatitis E | Q326643 | ||
hepatitis E virus | Q5731737 | ||
P304 | page(s) | 934-940 | |
P577 | publication date | 2004-06-01 | |
P1433 | published in | Transfusion | Q15758500 |
P1476 | title | Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan | |
P478 | volume | 44 |
Q36540997 | A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan. |
Q44598882 | A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes |
Q28069291 | Acute Hepatitis E: Two Sides of the Same Coin |
Q41722246 | Assessment of a transfusion emergent risk: the case of HEV |
Q37630325 | Autochthonous hepatitis e virus infections: a new transfusion-associated risk? |
Q27646563 | Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure |
Q40578368 | Chronic hepatitis E - an emerging disease in an immunocompromised host |
Q40000466 | Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report |
Q36417563 | Chronic hepatitis e infection resulting in graft failure in a liver transplant tourist |
Q33961593 | Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection |
Q42198637 | Clinical and molecular analyses of sporadic acute hepatitis A and E and the specific viral genotypes isolated in Iwate and three neighboring prefectures in the northern part of Honshu, Japan, between 2004 and 2013. |
Q37394249 | Comparative pathogenesis in specific-pathogen-free chickens of two strains of avian hepatitis E virus recovered from a chicken with Hepatitis-Splenomegaly syndrome and from a clinically healthy chicken |
Q33703351 | Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors |
Q38056078 | Culture systems for hepatitis E virus |
Q35690082 | Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3 |
Q34164503 | Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. |
Q35991946 | Economics of pathogen inactivation technology for platelet concentrates in Japan |
Q37835780 | Efficient cell culture systems for hepatitis E virus strains in feces and circulating blood. |
Q40330567 | Emergent viral threats in blood transfusion |
Q34068582 | Epidemiology of hepatitis e virus infection in patients on chronic hemodialysis |
Q38396830 | Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells |
Q45361732 | Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany |
Q38110609 | Features of hepatitis E virus infection in humans and animals in Japan |
Q92164533 | Genetic Variability and Evolution of Hepatitis E Virus |
Q40130228 | HEV and transfusion-recipient risk |
Q36805354 | Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran |
Q56656388 | Hepatitis E |
Q56915346 | Hepatitis E Virus |
Q56995087 | Hepatitis E Virus |
Q56995125 | Hepatitis E Virus |
Q36811948 | Hepatitis E Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV Infection |
Q33769640 | Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. |
Q35758900 | Hepatitis E Virus in Cambodia: Prevalence among the General Population and Complete Genome Sequence of Genotype 4 |
Q91715099 | Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study |
Q40601448 | Hepatitis E viral loads in plasma pools for fractionation |
Q38612287 | Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment. |
Q26751267 | Hepatitis E virus as an emerging zoonotic pathogen |
Q37098206 | Hepatitis E virus in developed countries: one of the most successful zoonotic viral diseases in human history? |
Q38538122 | Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety |
Q37544935 | Hepatitis E virus infection |
Q43347427 | Hepatitis E virus infection in Ghanaian blood donors - the importance of immunoassay selection and confirmation. |
Q37858676 | Hepatitis E virus infection in developed countries |
Q42274833 | Hepatitis E virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran |
Q33739483 | Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply |
Q38902776 | Hepatitis E virus seroprevalence among hemodialysis and hemophiliac patients in Tunisia (North Africa). |
Q42246567 | Hepatitis E virus seroprevalence and molecular study among blood donors in China |
Q45347479 | Hepatitis E virus seroprevalence before hematopoietic SCT: a pediatric experience |
Q45325570 | Hepatitis E virus subtype 3f strains isolated from Japanese hepatitis patients with no history of travel to endemic areas - The origin analyzed by molecular evolution. |
Q41722255 | Hepatitis E virus: Blood transfusion implications |
Q40967079 | Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors |
Q36487807 | Hepatitis E: An Underdiagnosed, Emerging Infection in Nonendemic Regions. |
Q28079743 | Hepatitis E: Discovery, global impact, control and cure |
Q34264481 | Hepatitis E: a complex and global disease |
Q38582155 | Hepatitis E: an emerging global disease - from discovery towards control and cure |
Q37320904 | Hepatitis E: an emerging infection in developed countries. |
Q35049128 | Hepatitis E: an old infection with new implications. |
Q38137898 | Hepatitis E: current status. |
Q38839954 | Hepatitis E: latest developments in knowledge. |
Q38192527 | Hepatitis e virus: current concepts and future perspectives |
Q42264440 | High genomic similarity between European type hepatitis E virus subgenotype 3e strains isolated from an acute hepatitis patient and a wild boar in Mie, Japan. |
Q37544940 | Host immune status and response to hepatitis E virus infection. |
Q92142831 | Identification of hepatitis E virus subtype 4f in blood donors in Shanghai, China |
Q40331422 | Incidence and duration of hepatitis E virus infection in Dutch blood donors |
Q37038794 | Incidence of Hepatitis E Virus Infection in Recipients of Blood or Blood Products Transfusion |
Q35991941 | Infectious risks associated with the transfusion of blood components and pathogen inactivation in Japan |
Q34232824 | Infectious swine hepatitis E virus is present in pig manure storage facilities on United States farms, but evidence of water contamination is lacking |
Q40507410 | Laboratory Diagnosis of HEV Infection |
Q40122194 | New viral risks in blood transfusion by 2016 |
Q36171437 | Novel approach for detection of hepatitis E virus infection in German blood donors |
Q45396822 | Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia |
Q45406183 | Prevalence of hepatitis E virus among wild boar in the Ehime area of western Japan. |
Q40390537 | Prevalence of hepatitis E virus infection among blood donors in mainland China: a meta-analysis |
Q44807693 | Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates |
Q50767714 | Prevention of transfusion-transmitted hepatitis E by donor-initiated self exclusion. |
Q77791813 | Probable transmission of hepatitis E virus (HEV) via transfusion in the United States |
Q45410039 | Quantitative detection of hepatitis E virus RNA and dynamics of viral replication in experimental infection |
Q42205129 | Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: Viral dynamics from onset to recovery |
Q45325825 | Re: Epidemiology of hepatitis E virus in children |
Q48012815 | Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report |
Q40078243 | Risk Factors Associated with Blood Exposure for Sporadic Hepatitis E in Dhaka, Bangladesh |
Q91686637 | Risk assessment for hepatitis E virus infection from domestic pigs introduced into an experimental animal facility in a medical school |
Q38268414 | Risk factors for hepatitis E virus infection and disease. |
Q33415330 | Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma |
Q28652630 | Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria |
Q40055954 | Seroprevalence and incidence of hepatitis E virus among blood donors: A review |
Q38398009 | Seroprevalence and incidence of hepatitis E virus infection in German blood donors |
Q35582431 | Seroprevalence of hepatitis E among Iranian renal transplant recipients |
Q41658138 | Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). |
Q91650627 | Seroprevalence of viral hepatitis A, B, C, D and E viruses in the Hormozgan province southern Iran |
Q59745217 | Significance of hepatitis E virus infection in HIV-infected patients: a challenging issue |
Q44761065 | Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan |
Q35067078 | Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance |
Q38962794 | The association of elevated alanine aminotransferase levels with hepatitis E virus infections among blood donors in China |
Q37960564 | The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. |
Q37877930 | The molecular epidemiology of hepatitis E virus infection |
Q34982710 | Three amino acid mutations (F51L, T59A, and S390L) in the capsid protein of the hepatitis E virus collectively contribute to virus attenuation |
Q49953709 | Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose. |
Q43220367 | Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. |
Q41960338 | Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes |
Q27480405 | Transfusion-transmitted infections |
Q52358472 | Transmission and Epidemiology of Hepatitis E Virus Genotype 3 and 4 Infections. |
Q40542632 | Transmission of Hepatitis E Virus |
Q28066465 | Transmission of Hepatitis E Virus in Developing Countries |
Q45348271 | Transmission of hepatitis E virus by transfusion: what is the risk? |
Q40350849 | Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression |
Q36825509 | World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. |
Q90743519 | [Risk of transmission of blood-derived pathogens by transfusion in Poland] |
Search more.